AIMC Topic: Botswana

Clear Filters Showing 1 to 1 of 1 articles

Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.

Antimicrobial agents and chemotherapy Sep 23, 2016
Aminoglycosides such as amikacin continue to be part of the backbone of treatment of multidrug-resistant tuberculosis (MDR-TB). We measured amikacin concentrations in 28 MDR-TB patients in Botswana receiving amikacin therapy together with oral levofl...
Humans Artificial Intelligence Female Aged Aged, 80 and over Young Adult Adult Male Middle Aged Microbial Sensitivity Tests Adolescent Models, Theoretical Treatment Outcome Regression Analysis Antitubercular Agents Tuberculosis, Multidrug-Resistant Tuberculosis, Pulmonary Mycobacterium tuberculosis Amikacin Botswana
View on PubMed DOI
Popular Topics
Recent Journals